nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2B6—malignant glioma	0.726	1	CbGaD
Fosphenytoin—CYP3A4—Temozolomide—malignant glioma	0.0309	1	CbGbCtD
Fosphenytoin—Pneumonia aspiration—Carmustine—malignant glioma	0.0063	0.0375	CcSEcCtD
Fosphenytoin—Brain oedema—Carmustine—malignant glioma	0.00481	0.0287	CcSEcCtD
Fosphenytoin—Brain oedema—Temozolomide—malignant glioma	0.00465	0.0277	CcSEcCtD
Fosphenytoin—Cerebral infarction—Carmustine—malignant glioma	0.00422	0.0251	CcSEcCtD
Fosphenytoin—Hemiplegia—Carmustine—malignant glioma	0.00385	0.0229	CcSEcCtD
Fosphenytoin—Hemiplegia—Temozolomide—malignant glioma	0.00372	0.0222	CcSEcCtD
Fosphenytoin—Hyperacusis—Temozolomide—malignant glioma	0.00357	0.0213	CcSEcCtD
Fosphenytoin—Meningitis—Carmustine—malignant glioma	0.00355	0.0211	CcSEcCtD
Fosphenytoin—Intracranial pressure increased—Carmustine—malignant glioma	0.00329	0.0196	CcSEcCtD
Fosphenytoin—Personality disorder—Carmustine—malignant glioma	0.00318	0.0189	CcSEcCtD
Fosphenytoin—Cerebral haemorrhage—Carmustine—malignant glioma	0.00248	0.0148	CcSEcCtD
Fosphenytoin—Cerebral haemorrhage—Temozolomide—malignant glioma	0.0024	0.0143	CcSEcCtD
Fosphenytoin—Myasthenia—Carmustine—malignant glioma	0.00219	0.013	CcSEcCtD
Fosphenytoin—Encephalopathy—Carmustine—malignant glioma	0.00214	0.0128	CcSEcCtD
Fosphenytoin—Aphasia—Carmustine—malignant glioma	0.00212	0.0126	CcSEcCtD
Fosphenytoin—Aphasia—Temozolomide—malignant glioma	0.00205	0.0122	CcSEcCtD
Fosphenytoin—Parosmia—Temozolomide—malignant glioma	0.00205	0.0122	CcSEcCtD
Fosphenytoin—Hypokinesia—Carmustine—malignant glioma	0.00204	0.0121	CcSEcCtD
Fosphenytoin—Myopathy—Temozolomide—malignant glioma	0.0019	0.0113	CcSEcCtD
Fosphenytoin—Stupor—Carmustine—malignant glioma	0.00184	0.011	CcSEcCtD
Fosphenytoin—Scotoma—Carmustine—malignant glioma	0.00181	0.0108	CcSEcCtD
Fosphenytoin—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00177	0.0105	CcSEcCtD
Fosphenytoin—Scotoma—Temozolomide—malignant glioma	0.00175	0.0104	CcSEcCtD
Fosphenytoin—Hyperaesthesia—Temozolomide—malignant glioma	0.00169	0.0101	CcSEcCtD
Fosphenytoin—Injection site pain—Carmustine—malignant glioma	0.00168	0.01	CcSEcCtD
Fosphenytoin—Petechiae—Temozolomide—malignant glioma	0.00162	0.00963	CcSEcCtD
Fosphenytoin—Speech disorder—Carmustine—malignant glioma	0.0016	0.00953	CcSEcCtD
Fosphenytoin—Accidental injury—Carmustine—malignant glioma	0.00155	0.00926	CcSEcCtD
Fosphenytoin—Speech disorder—Temozolomide—malignant glioma	0.00155	0.00921	CcSEcCtD
Fosphenytoin—Thinking abnormal—Carmustine—malignant glioma	0.0015	0.00895	CcSEcCtD
Fosphenytoin—Leukocytosis—Carmustine—malignant glioma	0.00146	0.00872	CcSEcCtD
Fosphenytoin—Coordination abnormal—Carmustine—malignant glioma	0.0014	0.00835	CcSEcCtD
Fosphenytoin—Pulmonary embolism—Carmustine—malignant glioma	0.00138	0.0082	CcSEcCtD
Fosphenytoin—Injection site reaction—Carmustine—malignant glioma	0.00137	0.00815	CcSEcCtD
Fosphenytoin—Coordination abnormal—Temozolomide—malignant glioma	0.00135	0.00806	CcSEcCtD
Fosphenytoin—Pulmonary embolism—Temozolomide—malignant glioma	0.00133	0.00792	CcSEcCtD
Fosphenytoin—Vaginal inflammation—Temozolomide—malignant glioma	0.00133	0.00792	CcSEcCtD
Fosphenytoin—Urinary incontinence—Carmustine—malignant glioma	0.00133	0.00791	CcSEcCtD
Fosphenytoin—Depressed level of consciousness—Carmustine—malignant glioma	0.00133	0.00791	CcSEcCtD
Fosphenytoin—Urinary incontinence—Temozolomide—malignant glioma	0.00128	0.00765	CcSEcCtD
Fosphenytoin—Depressed level of consciousness—Temozolomide—malignant glioma	0.00128	0.00765	CcSEcCtD
Fosphenytoin—Coma—Carmustine—malignant glioma	0.00126	0.00749	CcSEcCtD
Fosphenytoin—Vaginal infection—Temozolomide—malignant glioma	0.00125	0.00748	CcSEcCtD
Fosphenytoin—Mental disability—Carmustine—malignant glioma	0.00119	0.00711	CcSEcCtD
Fosphenytoin—Sepsis—Carmustine—malignant glioma	0.00119	0.00711	CcSEcCtD
Fosphenytoin—Mental disability—Temozolomide—malignant glioma	0.00115	0.00687	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Carmustine—malignant glioma	0.00115	0.00687	CcSEcCtD
Fosphenytoin—Ear pain—Temozolomide—malignant glioma	0.00113	0.00674	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Temozolomide—malignant glioma	0.00111	0.00664	CcSEcCtD
Fosphenytoin—Eye pain—Carmustine—malignant glioma	0.00111	0.00659	CcSEcCtD
Fosphenytoin—Injury—Carmustine—malignant glioma	0.00109	0.00647	CcSEcCtD
Fosphenytoin—Deafness—Temozolomide—malignant glioma	0.00108	0.00643	CcSEcCtD
Fosphenytoin—Eye pain—Temozolomide—malignant glioma	0.00107	0.00637	CcSEcCtD
Fosphenytoin—Amnesia—Carmustine—malignant glioma	0.00106	0.00633	CcSEcCtD
Fosphenytoin—Amnesia—Temozolomide—malignant glioma	0.00103	0.00612	CcSEcCtD
Fosphenytoin—Diplopia—Carmustine—malignant glioma	0.000998	0.00595	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000998	0.00595	CcSEcCtD
Fosphenytoin—Diplopia—Temozolomide—malignant glioma	0.000965	0.00575	CcSEcCtD
Fosphenytoin—Face oedema—Carmustine—malignant glioma	0.000964	0.00574	CcSEcCtD
Fosphenytoin—Affect lability—Temozolomide—malignant glioma	0.00095	0.00566	CcSEcCtD
Fosphenytoin—Methylphenobarbital—CYP2B6—malignant glioma	0.000939	0.194	CrCbGaD
Fosphenytoin—Ataxia—Carmustine—malignant glioma	0.000939	0.00559	CcSEcCtD
Fosphenytoin—Face oedema—Temozolomide—malignant glioma	0.000931	0.00555	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Carmustine—malignant glioma	0.000922	0.00549	CcSEcCtD
Fosphenytoin—Mood swings—Temozolomide—malignant glioma	0.000914	0.00545	CcSEcCtD
Fosphenytoin—Hypokalaemia—Carmustine—malignant glioma	0.000909	0.00541	CcSEcCtD
Fosphenytoin—Ataxia—Temozolomide—malignant glioma	0.000907	0.00541	CcSEcCtD
Fosphenytoin—Dehydration—Temozolomide—malignant glioma	0.000897	0.00535	CcSEcCtD
Fosphenytoin—Phenytoin—CYP2C18—malignant glioma	0.000888	0.183	CrCbGaD
Fosphenytoin—Muscular weakness—Carmustine—malignant glioma	0.000881	0.00525	CcSEcCtD
Fosphenytoin—Hypokalaemia—Temozolomide—malignant glioma	0.000878	0.00523	CcSEcCtD
Fosphenytoin—Dysphagia—Carmustine—malignant glioma	0.000863	0.00514	CcSEcCtD
Fosphenytoin—Muscular weakness—Temozolomide—malignant glioma	0.000851	0.00507	CcSEcCtD
Fosphenytoin—Dysphagia—Temozolomide—malignant glioma	0.000834	0.00497	CcSEcCtD
Fosphenytoin—Bronchitis—Temozolomide—malignant glioma	0.000802	0.00478	CcSEcCtD
Fosphenytoin—Dysuria—Temozolomide—malignant glioma	0.00078	0.00465	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Carmustine—malignant glioma	0.000778	0.00464	CcSEcCtD
Fosphenytoin—Pneumonia—Carmustine—malignant glioma	0.000774	0.00461	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Temozolomide—malignant glioma	0.000761	0.00454	CcSEcCtD
Fosphenytoin—Renal failure—Carmustine—malignant glioma	0.000756	0.00451	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Temozolomide—malignant glioma	0.000752	0.00448	CcSEcCtD
Fosphenytoin—Pneumonia—Temozolomide—malignant glioma	0.000748	0.00446	CcSEcCtD
Fosphenytoin—Modafinil—CYP2B6—malignant glioma	0.000743	0.153	CrCbGaD
Fosphenytoin—Sinusitis—Temozolomide—malignant glioma	0.000698	0.00416	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Carmustine—malignant glioma	0.000687	0.00409	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Temozolomide—malignant glioma	0.000664	0.00396	CcSEcCtD
Fosphenytoin—Pharyngitis—Temozolomide—malignant glioma	0.000662	0.00395	CcSEcCtD
Fosphenytoin—Phenytoin—CYP2B6—malignant glioma	0.000659	0.136	CrCbGaD
Fosphenytoin—Modafinil—SLC6A3—malignant glioma	0.000633	0.131	CrCbGaD
Fosphenytoin—Phenylbutazone—PTGS1—malignant glioma	0.000624	0.129	CrCbGaD
Fosphenytoin—Tinnitus—Temozolomide—malignant glioma	0.000622	0.00371	CcSEcCtD
Fosphenytoin—Chills—Temozolomide—malignant glioma	0.000599	0.00357	CcSEcCtD
Fosphenytoin—Back pain—Carmustine—malignant glioma	0.000582	0.00347	CcSEcCtD
Fosphenytoin—Dysgeusia—Temozolomide—malignant glioma	0.000569	0.00339	CcSEcCtD
Fosphenytoin—Tremor—Carmustine—malignant glioma	0.000563	0.00336	CcSEcCtD
Fosphenytoin—Back pain—Temozolomide—malignant glioma	0.000562	0.00335	CcSEcCtD
Fosphenytoin—Anaemia—Carmustine—malignant glioma	0.000556	0.00331	CcSEcCtD
Fosphenytoin—Agitation—Carmustine—malignant glioma	0.000553	0.00329	CcSEcCtD
Fosphenytoin—Tremor—Temozolomide—malignant glioma	0.000544	0.00324	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Temozolomide—malignant glioma	0.000539	0.00321	CcSEcCtD
Fosphenytoin—Leukopenia—Carmustine—malignant glioma	0.000538	0.00321	CcSEcCtD
Fosphenytoin—Anaemia—Temozolomide—malignant glioma	0.000537	0.0032	CcSEcCtD
Fosphenytoin—Agitation—Temozolomide—malignant glioma	0.000534	0.00318	CcSEcCtD
Fosphenytoin—Malaise—Temozolomide—malignant glioma	0.000524	0.00312	CcSEcCtD
Fosphenytoin—Vertigo—Temozolomide—malignant glioma	0.000522	0.00311	CcSEcCtD
Fosphenytoin—Convulsion—Carmustine—malignant glioma	0.000521	0.0031	CcSEcCtD
Fosphenytoin—Leukopenia—Temozolomide—malignant glioma	0.00052	0.0031	CcSEcCtD
Fosphenytoin—Hypertension—Carmustine—malignant glioma	0.000519	0.00309	CcSEcCtD
Fosphenytoin—Palpitations—Temozolomide—malignant glioma	0.000513	0.00306	CcSEcCtD
Fosphenytoin—Myalgia—Carmustine—malignant glioma	0.000512	0.00305	CcSEcCtD
Fosphenytoin—Cough—Temozolomide—malignant glioma	0.000507	0.00302	CcSEcCtD
Fosphenytoin—Convulsion—Temozolomide—malignant glioma	0.000503	0.003	CcSEcCtD
Fosphenytoin—Hypertension—Temozolomide—malignant glioma	0.000502	0.00299	CcSEcCtD
Fosphenytoin—Confusional state—Carmustine—malignant glioma	0.000495	0.00295	CcSEcCtD
Fosphenytoin—Myalgia—Temozolomide—malignant glioma	0.000495	0.00295	CcSEcCtD
Fosphenytoin—Arthralgia—Temozolomide—malignant glioma	0.000495	0.00295	CcSEcCtD
Fosphenytoin—Discomfort—Temozolomide—malignant glioma	0.000489	0.00291	CcSEcCtD
Fosphenytoin—Infection—Carmustine—malignant glioma	0.000487	0.0029	CcSEcCtD
Fosphenytoin—Dry mouth—Temozolomide—malignant glioma	0.000484	0.00288	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Carmustine—malignant glioma	0.00048	0.00286	CcSEcCtD
Fosphenytoin—Tachycardia—Carmustine—malignant glioma	0.000479	0.00285	CcSEcCtD
Fosphenytoin—Confusional state—Temozolomide—malignant glioma	0.000478	0.00285	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Temozolomide—malignant glioma	0.000474	0.00283	CcSEcCtD
Fosphenytoin—Infection—Temozolomide—malignant glioma	0.000471	0.00281	CcSEcCtD
Fosphenytoin—Anorexia—Carmustine—malignant glioma	0.000468	0.00279	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Temozolomide—malignant glioma	0.000464	0.00277	CcSEcCtD
Fosphenytoin—Hypotension—Carmustine—malignant glioma	0.000459	0.00273	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Temozolomide—malignant glioma	0.000458	0.00273	CcSEcCtD
Fosphenytoin—Anorexia—Temozolomide—malignant glioma	0.000452	0.00269	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000447	0.00266	CcSEcCtD
Fosphenytoin—Insomnia—Carmustine—malignant glioma	0.000444	0.00264	CcSEcCtD
Fosphenytoin—Paraesthesia—Carmustine—malignant glioma	0.000441	0.00263	CcSEcCtD
Fosphenytoin—Dyspnoea—Carmustine—malignant glioma	0.000437	0.00261	CcSEcCtD
Fosphenytoin—Somnolence—Carmustine—malignant glioma	0.000436	0.0026	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000432	0.00257	CcSEcCtD
Fosphenytoin—Insomnia—Temozolomide—malignant glioma	0.000429	0.00256	CcSEcCtD
Fosphenytoin—Decreased appetite—Carmustine—malignant glioma	0.000427	0.00254	CcSEcCtD
Fosphenytoin—Paraesthesia—Temozolomide—malignant glioma	0.000426	0.00254	CcSEcCtD
Fosphenytoin—Dyspnoea—Temozolomide—malignant glioma	0.000423	0.00252	CcSEcCtD
Fosphenytoin—Somnolence—Temozolomide—malignant glioma	0.000422	0.00251	CcSEcCtD
Fosphenytoin—Constipation—Carmustine—malignant glioma	0.00042	0.0025	CcSEcCtD
Fosphenytoin—Dyspepsia—Temozolomide—malignant glioma	0.000417	0.00249	CcSEcCtD
Fosphenytoin—Decreased appetite—Temozolomide—malignant glioma	0.000412	0.00246	CcSEcCtD
Fosphenytoin—Constipation—Temozolomide—malignant glioma	0.000405	0.00242	CcSEcCtD
Fosphenytoin—Feeling abnormal—Carmustine—malignant glioma	0.000404	0.00241	CcSEcCtD
Fosphenytoin—Feeling abnormal—Temozolomide—malignant glioma	0.000391	0.00233	CcSEcCtD
Fosphenytoin—Body temperature increased—Carmustine—malignant glioma	0.000388	0.00231	CcSEcCtD
Fosphenytoin—Urticaria—Temozolomide—malignant glioma	0.000377	0.00224	CcSEcCtD
Fosphenytoin—Body temperature increased—Temozolomide—malignant glioma	0.000375	0.00223	CcSEcCtD
Fosphenytoin—Phenylbutazone—PTGS2—malignant glioma	0.000357	0.0737	CrCbGaD
Fosphenytoin—Asthenia—Carmustine—malignant glioma	0.000352	0.0021	CcSEcCtD
Fosphenytoin—Asthenia—Temozolomide—malignant glioma	0.00034	0.00203	CcSEcCtD
Fosphenytoin—Diarrhoea—Carmustine—malignant glioma	0.000336	0.002	CcSEcCtD
Fosphenytoin—Pruritus—Temozolomide—malignant glioma	0.000335	0.002	CcSEcCtD
Fosphenytoin—Dizziness—Carmustine—malignant glioma	0.000324	0.00193	CcSEcCtD
Fosphenytoin—Diarrhoea—Temozolomide—malignant glioma	0.000324	0.00193	CcSEcCtD
Fosphenytoin—Dizziness—Temozolomide—malignant glioma	0.000314	0.00187	CcSEcCtD
Fosphenytoin—Vomiting—Carmustine—malignant glioma	0.000312	0.00186	CcSEcCtD
Fosphenytoin—Rash—Carmustine—malignant glioma	0.000309	0.00184	CcSEcCtD
Fosphenytoin—Dermatitis—Carmustine—malignant glioma	0.000309	0.00184	CcSEcCtD
Fosphenytoin—Headache—Carmustine—malignant glioma	0.000307	0.00183	CcSEcCtD
Fosphenytoin—Vomiting—Temozolomide—malignant glioma	0.000301	0.0018	CcSEcCtD
Fosphenytoin—Rash—Temozolomide—malignant glioma	0.000299	0.00178	CcSEcCtD
Fosphenytoin—Dermatitis—Temozolomide—malignant glioma	0.000299	0.00178	CcSEcCtD
Fosphenytoin—Headache—Temozolomide—malignant glioma	0.000297	0.00177	CcSEcCtD
Fosphenytoin—Nausea—Carmustine—malignant glioma	0.000291	0.00174	CcSEcCtD
Fosphenytoin—Nausea—Temozolomide—malignant glioma	0.000282	0.00168	CcSEcCtD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.96e-05	0.000706	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—COX8A—malignant glioma	4.89e-05	0.000696	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—MMP2—malignant glioma	4.89e-05	0.000696	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—TP53—malignant glioma	4.7e-05	0.00067	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—FGF2—malignant glioma	4.64e-05	0.000661	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—VEGFA—malignant glioma	4.62e-05	0.000658	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.6e-05	0.000655	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	4.59e-05	0.000653	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.45e-05	0.000634	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—RAF1—malignant glioma	4.33e-05	0.000616	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—ERBB2—malignant glioma	4.28e-05	0.00061	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—TNF—malignant glioma	4.24e-05	0.000604	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.19e-05	0.000597	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—EGFR—malignant glioma	4.16e-05	0.000592	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ASMT—malignant glioma	4.16e-05	0.000592	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—COX8A—malignant glioma	4.14e-05	0.00059	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	4.14e-05	0.000589	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	4.14e-05	0.000589	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—COX8A—malignant glioma	4.12e-05	0.000586	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.06e-05	0.000578	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—H3F3A—malignant glioma	4e-05	0.00057	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	3.96e-05	0.000564	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—KRAS—malignant glioma	3.93e-05	0.00056	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	3.91e-05	0.000557	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—BCAN—malignant glioma	3.91e-05	0.000557	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—RTEL1—malignant glioma	3.87e-05	0.000551	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.83e-05	0.000545	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	3.77e-05	0.000538	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.7e-05	0.000527	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—COX8A—malignant glioma	3.7e-05	0.000526	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.68e-05	0.000524	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—MMP9—malignant glioma	3.67e-05	0.000523	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	3.62e-05	0.000516	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ASMT—malignant glioma	3.52e-05	0.000501	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ASMT—malignant glioma	3.5e-05	0.000499	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	3.5e-05	0.000498	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	3.48e-05	0.000496	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.44e-05	0.00049	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.42e-05	0.000487	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—COX8A—malignant glioma	3.37e-05	0.00048	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—BCAN—malignant glioma	3.31e-05	0.000471	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.3e-05	0.00047	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—KNG1—malignant glioma	3.3e-05	0.00047	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—VEGFA—malignant glioma	3.3e-05	0.00047	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—BCAN—malignant glioma	3.29e-05	0.000469	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—STAT3—malignant glioma	3.27e-05	0.000465	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IFNA2—malignant glioma	3.23e-05	0.00046	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.21e-05	0.000458	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—IDH2—malignant glioma	3.15e-05	0.000449	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ASMT—malignant glioma	3.14e-05	0.000448	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	3.11e-05	0.000442	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.07e-05	0.000437	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SOD1—malignant glioma	3.06e-05	0.000436	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.06e-05	0.000436	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	3.03e-05	0.000432	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.01e-05	0.000429	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—EGFR—malignant glioma	2.97e-05	0.000423	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—BCAN—malignant glioma	2.95e-05	0.000421	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ASMT—malignant glioma	2.87e-05	0.000408	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—TNF—malignant glioma	2.83e-05	0.000403	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PTK2—malignant glioma	2.81e-05	0.000401	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—KRAS—malignant glioma	2.8e-05	0.000399	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.8e-05	0.000399	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	2.79e-05	0.000397	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—IDH1—malignant glioma	2.71e-05	0.000386	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—BCAN—malignant glioma	2.69e-05	0.000384	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—IDH2—malignant glioma	2.67e-05	0.00038	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—IDH2—malignant glioma	2.65e-05	0.000378	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—SPHK1—malignant glioma	2.62e-05	0.000373	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP2C18—malignant glioma	2.57e-05	0.000366	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.52e-05	0.000358	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP2B6—malignant glioma	2.51e-05	0.000357	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.5e-05	0.000356	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP2B6—malignant glioma	2.49e-05	0.000355	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—IDH2—malignant glioma	2.38e-05	0.000339	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	2.37e-05	0.000337	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PDGFB—malignant glioma	2.36e-05	0.000337	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—IDH1—malignant glioma	2.29e-05	0.000327	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—IDH1—malignant glioma	2.28e-05	0.000325	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.25e-05	0.00032	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—CAV1—malignant glioma	2.24e-05	0.000319	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP2B6—malignant glioma	2.24e-05	0.000319	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—COX8A—malignant glioma	2.22e-05	0.000316	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—SPHK1—malignant glioma	2.22e-05	0.000316	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—SPHK1—malignant glioma	2.21e-05	0.000314	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP2C18—malignant glioma	2.17e-05	0.00031	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—IDH2—malignant glioma	2.17e-05	0.000309	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP2C18—malignant glioma	2.16e-05	0.000308	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—F2—malignant glioma	2.13e-05	0.000304	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—FN1—malignant glioma	2.13e-05	0.000304	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—AKT1—malignant glioma	2.1e-05	0.0003	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTT1—malignant glioma	2.08e-05	0.000296	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.05e-05	0.000292	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—IDH1—malignant glioma	2.05e-05	0.000292	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.05e-05	0.000292	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.04e-05	0.000291	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CG—malignant glioma	2.04e-05	0.000291	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.04e-05	0.00029	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—EGF—malignant glioma	2.02e-05	0.000287	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PTPN11—malignant glioma	2e-05	0.000285	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SPHK1—malignant glioma	1.98e-05	0.000282	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTGS1—malignant glioma	1.95e-05	0.000277	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.94e-05	0.000276	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ASMT—malignant glioma	1.89e-05	0.000269	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.87e-05	0.000266	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—IDH1—malignant glioma	1.87e-05	0.000266	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—AKT2—malignant glioma	1.87e-05	0.000266	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.86e-05	0.000265	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.85e-05	0.000263	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.83e-05	0.000261	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—BCHE—malignant glioma	1.81e-05	0.000258	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SPHK1—malignant glioma	1.81e-05	0.000257	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.8e-05	0.000257	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CD—malignant glioma	1.79e-05	0.000255	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.79e-05	0.000255	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.79e-05	0.000255	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—BCAN—malignant glioma	1.78e-05	0.000253	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.77e-05	0.000252	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTT1—malignant glioma	1.76e-05	0.000251	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTT1—malignant glioma	1.75e-05	0.000249	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.67e-05	0.000238	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.67e-05	0.000237	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTGS1—malignant glioma	1.65e-05	0.000235	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.64e-05	0.000234	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTGS1—malignant glioma	1.64e-05	0.000233	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.63e-05	0.000233	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.61e-05	0.000229	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—RAF1—malignant glioma	1.6e-05	0.000228	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTT1—malignant glioma	1.57e-05	0.000224	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CB—malignant glioma	1.56e-05	0.000223	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—BCHE—malignant glioma	1.53e-05	0.000218	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—BCHE—malignant glioma	1.52e-05	0.000217	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.52e-05	0.000217	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.51e-05	0.000216	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.51e-05	0.000215	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—SLC5A5—malignant glioma	1.51e-05	0.000214	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTGS1—malignant glioma	1.47e-05	0.00021	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.47e-05	0.000209	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.47e-05	0.000209	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTP1—malignant glioma	1.44e-05	0.000205	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IL2—malignant glioma	1.44e-05	0.000204	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—IDH2—malignant glioma	1.43e-05	0.000204	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTT1—malignant glioma	1.43e-05	0.000204	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.43e-05	0.000204	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.42e-05	0.000203	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.42e-05	0.000202	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.41e-05	0.000201	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CAT—malignant glioma	1.4e-05	0.0002	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	1.39e-05	0.000197	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—BCHE—malignant glioma	1.37e-05	0.000195	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.35e-05	0.000192	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.35e-05	0.000192	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTGS1—malignant glioma	1.34e-05	0.000191	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.34e-05	0.00019	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NCOR1—malignant glioma	1.32e-05	0.000188	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.28e-05	0.000182	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.27e-05	0.00018	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—BCHE—malignant glioma	1.25e-05	0.000178	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.24e-05	0.000176	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.23e-05	0.000175	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—IDH1—malignant glioma	1.23e-05	0.000175	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.23e-05	0.000175	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—VEGFA—malignant glioma	1.22e-05	0.000174	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTP1—malignant glioma	1.22e-05	0.000174	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTP1—malignant glioma	1.21e-05	0.000173	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SPHK1—malignant glioma	1.19e-05	0.00017	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CAT—malignant glioma	1.19e-05	0.000169	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CAT—malignant glioma	1.18e-05	0.000168	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.17e-05	0.000166	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.17e-05	0.000166	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.15e-05	0.000164	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NCOR1—malignant glioma	1.12e-05	0.00016	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NCOR1—malignant glioma	1.11e-05	0.000159	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.1e-05	0.000157	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTP1—malignant glioma	1.09e-05	0.000155	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CAV1—malignant glioma	1.08e-05	0.000154	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CAT—malignant glioma	1.06e-05	0.000151	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—KRAS—malignant glioma	1.04e-05	0.000148	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.01e-05	0.000143	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NCOR1—malignant glioma	1e-05	0.000142	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTP1—malignant glioma	9.92e-06	0.000141	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CG—malignant glioma	9.83e-06	0.00014	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CAT—malignant glioma	9.66e-06	0.000138	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CA—malignant glioma	9.53e-06	0.000136	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PPARG—malignant glioma	9.48e-06	0.000135	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTT1—malignant glioma	9.44e-06	0.000134	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TP53—malignant glioma	9.22e-06	0.000131	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CAV1—malignant glioma	9.13e-06	0.00013	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NCOR1—malignant glioma	9.12e-06	0.00013	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CAV1—malignant glioma	9.08e-06	0.000129	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTGS1—malignant glioma	8.85e-06	0.000126	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.73e-06	0.000124	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.68e-06	0.000124	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CD—malignant glioma	8.64e-06	0.000123	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CG—malignant glioma	8.32e-06	0.000118	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CG—malignant glioma	8.27e-06	0.000118	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—BCHE—malignant glioma	8.22e-06	0.000117	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CAV1—malignant glioma	8.15e-06	0.000116	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC5A5—malignant glioma	8.12e-06	0.000116	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PPARG—malignant glioma	8.03e-06	0.000114	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PPARG—malignant glioma	7.98e-06	0.000114	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.79e-06	0.000111	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—AKT1—malignant glioma	7.79e-06	0.000111	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CB—malignant glioma	7.53e-06	0.000107	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTGS2—malignant glioma	7.46e-06	0.000106	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CAV1—malignant glioma	7.43e-06	0.000106	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CG—malignant glioma	7.43e-06	0.000106	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CD—malignant glioma	7.31e-06	0.000104	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CD—malignant glioma	7.27e-06	0.000104	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PPARG—malignant glioma	7.17e-06	0.000102	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.1e-06	0.000101	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.77e-06	9.64e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTP1—malignant glioma	6.54e-06	9.32e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PPARG—malignant glioma	6.54e-06	9.31e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CD—malignant glioma	6.53e-06	9.3e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTEN—malignant glioma	6.51e-06	9.27e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CB—malignant glioma	6.37e-06	9.08e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CAT—malignant glioma	6.37e-06	9.07e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CB—malignant glioma	6.34e-06	9.03e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTGS2—malignant glioma	6.32e-06	9e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTGS2—malignant glioma	6.28e-06	8.94e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOR1—malignant glioma	6.01e-06	8.56e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.95e-06	8.48e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CB—malignant glioma	5.69e-06	8.1e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTGS2—malignant glioma	5.64e-06	8.03e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTEN—malignant glioma	5.51e-06	7.85e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTEN—malignant glioma	5.48e-06	7.8e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.19e-06	7.39e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTGS2—malignant glioma	5.14e-06	7.32e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTEN—malignant glioma	4.92e-06	7e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CAV1—malignant glioma	4.9e-06	6.98e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CA—malignant glioma	4.59e-06	6.54e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTEN—malignant glioma	4.48e-06	6.38e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.47e-06	6.36e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PPARG—malignant glioma	4.31e-06	6.14e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.93e-06	5.59e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CA—malignant glioma	3.89e-06	5.53e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CA—malignant glioma	3.86e-06	5.5e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—AKT1—malignant glioma	3.75e-06	5.34e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CA—malignant glioma	3.47e-06	4.94e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.42e-06	4.87e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTGS2—malignant glioma	3.39e-06	4.83e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—AKT1—malignant glioma	3.17e-06	4.52e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.16e-06	4.5e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—AKT1—malignant glioma	3.16e-06	4.5e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTEN—malignant glioma	2.96e-06	4.21e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—AKT1—malignant glioma	2.83e-06	4.04e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—AKT1—malignant glioma	2.58e-06	3.68e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.09e-06	2.97e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—AKT1—malignant glioma	1.7e-06	2.43e-05	CbGpPWpGaD
